Author

P. Chawla

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Exploring the Potential of Quinoline-Containing Pyrazoline Derivatives as Antidepressant Agents: In Vivo and In Silico Studies.

INTRODUCTION/OBJECTIVE Depression is a common mental disorder, affecting over 300 million people worldwide. Currently available treatments, such as SSRIs, SNRIs, TCAs, and MAOIs, have limited effectiveness and cause side effects. The pharmacological potential of compounds based on diverse novel heterocyclic scaffolds,...

B. Sharma, Chahat, Pawan Kumar et al. · CNS and Neurological Disorde... · 0 citations

Editorial Aug 2026

Chemistry of Materials and Emerging Techniques: Future of Drug Discovery and Medicinal Product Developments.

<jats:sec> <jats:title/> <jats:p/> </jats:sec>

Md. Noushad Javed, P. Chawla, Mohd Javed Naim et al. · Mini-Reviews in Medical Chem... · 0 citations

Open access Sep 2026

Rational Design, Synthesis, Biological Evaluation, and In Silico Study of N‐Cinnamamide/Benzamide‐(4‐(Substituted Phenyl)‐6‐(4‐Cyclohexylphenyl)pyrimidin‐2‐Yl) Derivatives as EGFR Inhibitors Targeting EGFRWT , EGFRT790M , and EGFRL858R /T790M/C797S in NSCLC

A series of novel N‐Cinnamamide/benzamide‐(4‐(substituted phenyl)‐6‐(4‐cyclohexylphenyl)pyrimidin‐2‐yl) derivatives (Ri–Rxii) as EGFR inhibitors exhibited superior antiproliferative activity against wild‐type and mutant EGFR‐driven NSCLC cell lines, and was a strong candidate for overcoming drug resistance in NSCLC tre...

Rohit Pal, G. S. P. Matada, Ghanshyam Teli et al. · Chemical Biology and Drug De... · 0 citations